Our Magazine
Brussels Morning Online Newspaper
Thursday, February 25, 2021
No Result
View All Result
  • Home
    • About Us
  • EU institutions
    • Commission
    • Parliament
    • Council
  • Europe
  • World
  • Economy
  • Culture and Society
  • In Depth
    • Ambassador’s Corner
    • The American Angle
    • Europe With Transparency
    • Sustainable Perspective
    • Place de la Bourse
    • The Macro-Economist
    • Southeast Europe
Brussels Morning Online Newspaper
  • Home
    • About Us
  • EU institutions
    • Commission
    • Parliament
    • Council
  • Europe
  • World
  • Economy
  • Culture and Society
  • In Depth
    • Ambassador’s Corner
    • The American Angle
    • Europe With Transparency
    • Sustainable Perspective
    • Place de la Bourse
    • The Macro-Economist
    • Southeast Europe
Brussels Morning Online Newspaper
No Result
View All Result
Home EU Institutions Commission

EC announces new mechanism to refuse vaccine exports

Ivan Fischer by Ivan Fischer
28 January 2021
in Commission
EC announces new mechanism to refuse vaccine exports

EU Coronavirus vaccine, Europe. Covid-19 vaccination, flu prevention, immunization concept. Vial dose and medical syringe, European Union flag background.

Share on FacebookShare on Twitter

Brussels (Brussels Morning) The European Commission announced the establishment of a new mechanism which would provide national drug regulators with the authority to refuse vaccine exports from their countries, Reuters reported on Thursday.

The move comes in response to the announcement of reduced deliveries of the new coronavirus vaccine by the British-Swedish pharma giant AstraZeneca, which shipped part of its EU production stock to the UK last year, but now refuses to do the reverse, citing contractual obligations.

Not an export ban

An EU official quoted by Reuters said the new measure does not amount to an export ban. “We are now in a situation where we have a lack of clarity on vaccine deliveries which creates concerns for all of us and most of all for our citizens. We are obliged to look for a solution to this situation,” the official declared.

The new system would require all producers planning to export their vaccines from the European Union to provide the local regulatory agency with the export plans “We want to know whether it goes in the right direction,” the official noted, adding that, depending on the criteria,  this could lead to a refusal. 

Belgian facility

The new monitoring and authorisation system could impact the delivery of Pfizer’s vaccine to Britain and Canada, for instance, as both countries are awaiting deliveries from the company’s factory in Belgium. Ostensibly, the mechanism could be used to stop exports should the producer have failed to fulfill its commitments to the bloc.
The EU invested 336 million euro in AstraZeneca, in return for 400 million doses of its vaccine. After the pharma giant announced delays in delivery, while keeping up with the UK contract deadlines, the EU lawyers started investigating whether there has been a breach of contract.

Tags: European Commission (EC)Vaccinevaccine contracts
Ivan Fischer

Ivan Fischer

Ivan is a Zagreb-based journalist with extensive experience in covering European and global politics, economy and emerging technology challenges. He is a foreign policy reporter for the leading Croatian daily Jutarnji list, as well as an alumnus of several journalism training programmes organised by Thomson Reuters Foundation and Robert Bosch Stiftung.

Latest post

EU considering vaccination passports

EU considering vaccination passports

7 mins ago
EU authorities seize 23 tonnes of cocaine in Germany and Belgium

EU authorities seize 23 tonnes of cocaine in Germany and Belgium

25 mins ago

Most Read

  • Georgia committed and ready for NATO membership

    Georgia committed and ready for NATO membership

    0 shares
    Share 0 Tweet 0
  • The EU will not learn to speak the language of power as long as Germany does not

    0 shares
    Share 0 Tweet 0
  • For US Cybersecurity China is a bigger concern than Russia

    0 shares
    Share 0 Tweet 0
  • Consumption of plant-based alternatives is disconcerting to meat and dairy industries

    0 shares
    Share 0 Tweet 0
  • Biden Administration opens the door to international green energy know-how

    0 shares
    Share 0 Tweet 0

Subscribe
Facebook Twitter Youtube LinkedIn

About Us

Brussels Morning is a daily online newspaper based in Belgium. BM publishes unique and independent coverage on international and European affairs. With a Europe-wide perspective, BM covers policies and politics of the EU, significant Member State developments, and looks at the international agenda with a European perspective.

Category

  • Ambassador’s Corner
  • Commission
  • Council
  • Culture and Society
  • Diplomacy
  • Economy
  • EU Institutions
  • Europe
  • Europe With Transparency
  • Features
  • In Depth
  • Member States
  • Middle East Eye
  • Opinion
  • Our pick
  • Parliament
  • Place de la Bourse
  • Southeast Europe
  • Sustainable Perspective
  • The American Angle
  • The Macro-Economist
  • Uncategorised
  • US Elections
  • World

More info

  • About Us
  • Advertising
  • Cookies Policy
  • Contact Us
  • FAQ
  • Jobs

Brussels Morning Newspaper - All Rights Reserved © 2020

No Result
View All Result
  • Home
  • About Us
  • EU Institutions
    • Parliament
    • Commission
    • Council
  • Europe
  • World
  • Member States
  • Economy
  • Culture and Society
  • In Depth
    • Ambassador’s Corner
    • Europe With Transparency
    • Place de la Bourse
    • The Macro-Economist
    • Sustainable Perspective
    • The American Angle
    • Southeast Europe
  • Magazine

Brussels Morning Newspaper - All Rights Reserved © 2020

Welcome Back!

Login to your account below

Forgotten Password?

Create New Account!

Fill the forms below to register

All fields are required. Log In

Retrieve your password

Please enter your username or email address to reset your password.

Log In
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking “Accept”, you consent to the use of ALL the cookies.
Cookie settingsACCEPT
Privacy & Cookies Policy

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these cookies, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may have an effect on your browsing experience.
Necessary
Always Enabled

Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.

Non-necessary

Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.

SAVE & ACCEPT